Cite
Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer
MLA
Tiantian Tan, et al. “Cabazitaxel-Loaded Human Serum Albumin Nanoparticles Combined with TGFβ-1 SiRNA Lipid Nanoparticles for the Treatment of Paclitaxel-Resistant Non-Small Cell Lung Cancer.” Cancer Nanotechnology, vol. 14, no. 1, July 2023, pp. 1–34. EBSCOhost, https://doi.org/10.1186/s12645-023-00194-7.
APA
Tiantian Tan, Yuxin Feng, Weimin Wang, Rongrong Wang, Liyan Yin, Yiying Zeng, Zhaowu Zeng, & Tian Xie. (2023). Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer. Cancer Nanotechnology, 14(1), 1–34. https://doi.org/10.1186/s12645-023-00194-7
Chicago
Tiantian Tan, Yuxin Feng, Weimin Wang, Rongrong Wang, Liyan Yin, Yiying Zeng, Zhaowu Zeng, and Tian Xie. 2023. “Cabazitaxel-Loaded Human Serum Albumin Nanoparticles Combined with TGFβ-1 SiRNA Lipid Nanoparticles for the Treatment of Paclitaxel-Resistant Non-Small Cell Lung Cancer.” Cancer Nanotechnology 14 (1): 1–34. doi:10.1186/s12645-023-00194-7.